Anthony Gonçalvès - Researcher Profile

Publications

2 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

2020 The Lancet 1658 citations

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton , Hope S. Rugo , Johannes Ettl +15 more

Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...

2018 New England Journal of Medicine 1983 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,641
Institution: Institut Paoli-Calmettes

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7570-7439

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.